ストックスクリーナーアプリを入手
21.50
4.47%
-1.0664
Baxter International Inc (BAX) 最新ニュース
Goldman Sachs Adjusts Price Target on Baxter International to $21 From $19, Maintains Neutral Rating - marketscreener.com
ETFs Investing in Baxter International Inc. Stocks - TradingView
Baxter stock reflects a diversified medical technology business - ad-hoc-news.de
Baxter International stock reflects a diversified medical portfolio and ongoing portfolio transforma - ad-hoc-news.de
Baxter International Inc. (BAX) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors - Business Wire
Retia Medical Adds Former Baxter Executive Christopher Benassi to Advisory Board - citybiz
Baxter International Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh - TradingView
Citi Sticks to Its Sell Rating for Baxter International (BAX) - The Globe and Mail
Baxter Beats Stable Value Fund 401(k) Plan Suit, For Good - Law360
A Look at Baxter International Inc (BAX) After 3.9% Decline -- G - GuruFocus
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Baxter International balances portfolio focus and steady operations - ad-hoc-news.de
Baxter International focuses on core medical technologies as investors watch US healthcare demand - ad-hoc-news.de
Baxter International Again Defeats 401(k) Stable Value Fund Suit - Bloomberg Law News
Baxter International (BAX) Is Up 7.2% After Dual Russell 2500 Index AdditionsWhat's Changed - simplywall.st
Baxter International's Q2 2026 Earnings: What to Expect - Yahoo Finance
The Sigma Spectrum Infusion SystemBaxter International targets smarter IV safety - ad-hoc-news.de
Baxter International focuses on core healthcare business as investors watch its portfolio moves - ad-hoc-news.de
Why Baxter International Inc (BAX) May Struggle to Outperform: A Look at Future Challenges - GuruFocus
Is Baxter International (BAX) Fully Valued On Its Russell 2500 Index Additions? - Yahoo Finance
Will Dual Russell 2500 Inclusion and Stronger Sentiment Change Baxter International's (BAX) Narrative? - Yahoo Finance
Baxter International balances medical technology breadth with long-term investment themes - ad-hoc-news.de
Why Is Baxter (NYSE:BAX) Featured Across Major US Indices? - Kalkine Media
Baxter International focuses on core portfolio as investors weigh long-term growth prospects - ad-hoc-news.de
Evercore ISI Adjusts Price Target on Baxter International to $24 From $22 - Moomoo
Baxter International focuses on medical products as investors watch long-term strategy - ad-hoc-news.de
The Spectrum IQ Infusion System from Baxter Internationalsmart pumps push safer drug delivery - AD HOC NEWS
Baxter International focuses on medical products and patient care - AD HOC NEWS
The PrisMax SystemBaxter International extends care for chronic kidney patients - AD HOC NEWS
Baxter International Inc. Actuals & Estimates (SWB:BTL) - TradingView
How Baxter International Inc. (BAX) Affects Rotational Strategy Timing - Stock Traders Daily
Baxter International outlines its healthcare strategy as investors watch the stock - AD HOC NEWS
BAX News | BAXTER INTERNATIONAL INC (NYSE:BAX) - ChartMill
Baxter International Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Baxter International stock on the company backdrop. Trading stays tied to the wider health care setu - AD HOC NEWS
Evercore ISI Group Lowers Price Target for Baxter International (BAX) to $22 | BAX Stock News - GuruFocus
Baxter International outlines its healthcare focus as investors watch the stock - AD HOC NEWS
The Exacta HD dialyzerBaxter International targets high-flux performance for US dialysis centers - AD HOC NEWS
Global Human Fibrinogen Concentrate Market Size/Share Worth USD 2.78 Billion by 2035 at a 11.3% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
A Look at Baxter International Inc (BAX) After 3.2% Decline -- G - GuruFocus
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
BAX Investors Have Opportunity to Lead Baxter International, Inc - The National Law Review
Baxter International consensus picture on Wall Street, shares trade steadily on NYSE - AD HOC NEWS
Is Baxter International stock underperforming the S&P 500? - MSN
Lazard Equity Franchise Portfolio's Baxter International Inc(BAX) Holding History - GuruFocus
Baxter Publishes 2025 Sustainability Report Highlighting Refreshed Strategy, Ongoing Commitment to Drive Meaningful Impact - Bioscience Association Manitoba
Baxter International, Inc. (BAX) LawsuitInvestors Urged to Contact Levi & Korsinsky Before December 15, 2025 - The National Law Review
Sigma Spectrum Infusion System from Baxter International Inc.smart alerts in a compact pump - ad-hoc-news.de
Baxter International Inc.(NYSE: BAX) added to Russell 2500 Index - marketscreener.com
Lost Money on Baxter International, Inc. (BAX)? Contact Levi & Ko - The National Law Review
Levi & Korsinsky Notifies Baxter International, Inc. (BAX) Shareh - The National Law Review
BAX ALERT: Securities Fraud Class Action Launched Against Baxter International, Inc.December 15, 2025 Deadline - The National Law Review
Recover Investment Losses: Class Action Initiated Against Baxter International, Inc. (BAX) - The National Law Review
Did You Lose Money on Baxter International, Inc. (BAX)? Levi & Ko - The National Law Review
Class Action Filed Against Baxter International, Inc. (BAX) Over Securities ViolationsContact Levi & Korsinsky Today - The National Law Review
Securities Fraud Class Action Filed Against Baxter International - The National Law Review
Securities Class Action Lawsuit Filed Against Baxter Internationa - The National Law Review
Investors in Baxter International, Inc. (BAX): Protect Your RightsContact Levi & Korsinsky Before December 15, 2025 - The National Law Review
Investors SueWallSt Over Baxter International, Inc. Stock Drop - The National Law Review
Securities Lawsuit Alert: Baxter International, Inc. (BAX) InvestorsContact Levi & Korsinsky Before December 15, 2025 - The National Law Review
Investor Alert: Deadline Approaching to Join Baxter International, Inc. (BAX) Class ActionContact Levi & Korsinsky - The National Law Review
Levi & Korsinsky Notifies Baxter International, Inc. (BAX) InvestorsLead Plaintiff Deadline on December 15, 2025 - The National Law Review
BAX LAWSUIT ALERT: Levi & Korsinsky Notifies Baxter International - The National Law Review
Baxter International edges higher with sector peers, shares trade on NYSE - AD HOC NEWS
Baxter's unit Synovis MCA to lead global rollout of the SHIYA platform - MSN
Baxter International Inc.(NYSE: BAX) added to Russell 2500 Value Benchmark - marketscreener.com
The PrisMax System from Baxter International Inc.flexible CRRT for fragile ICU patients - AD HOC NEWS
0.68%
大文字化:
|
ボリューム (24 時間):